日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

When Can One Vaccinate with a Live Vaccine after Wild-Type Dengue Infection?

感染野生型登革热病毒后,何时可以接种活疫苗?

Guy, Bruno; Ooi, Eng Eong; Ramos-Castañeda, Jose; Thomas, Stephen J

Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults

一种四价植物源病毒样颗粒流感候选疫苗的免疫原性和安全性——两项针对18至49岁和≥50岁成年人的随机II期临床试验

Pillet, Stéphane; Couillard, Julie; Trépanier, Sonia; Poulin, Jean-François; Yassine-Diab, Bader; Guy, Bruno; Ward, Brian J; Landry, Nathalie

Dissecting Antibodies Induced by a Chimeric Yellow Fever-Dengue, Live-Attenuated, Tetravalent Dengue Vaccine (CYD-TDV) in Naive and Dengue-Exposed Individuals

分析嵌合黄热病-登革热减毒活四价登革热疫苗(CYD-TDV)在未感染和已感染登革热的个体中诱导产生的抗体

Henein, Sandra; Swanstrom, Jesica; Byers, Anthony M; Moser, Janice M; Shaik, S Farzana; Bonaparte, Matthew; Jackson, Nicholas; Guy, Bruno; Baric, Ralph; de Silva, Aravinda M

Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination

对四价登革热疫苗接种后长达4年的免疫原性进行综合分析

Vigne, Claire; Dupuy, Martin; Richetin, Aline; Guy, Bruno; Jackson, Nicholas; Bonaparte, Matthew; Hu, Branda; Saville, Melanie; Chansinghakul, Danaya; Noriega, Fernando; Plennevaux, Eric

Cytokine Profile of Children Hospitalized with Virologically-Confirmed Dengue during Two Phase III Vaccine Efficacy Trials

两项 III 期疫苗有效性试验中,病毒学确诊登革热住院患儿的细胞因子谱

Harenberg, Anke; de Montfort, Aymeric; Jantet-Blaudez, Frédérique; Bonaparte, Matthew; Boudet, Florence; Saville, Melanie; Jackson, Nicholas; Guy, Bruno

Influence of FcγRIIa-Expressing Cells on the Assessment of Neutralizing and Enhancing Serum Antibodies Elicited by a Live-Attenuated Tetravalent Dengue Vaccine

FcγRIIa表达细胞对减毒活四价登革热疫苗诱导的中和抗体和增强抗体评估的影响

Byers, Anthony M; Broder, Ryan; Haupfear, Kelly; Timiryasova, Tatyana M; Hu, Branda T; Boaz, Mark; Warren, William L; Jackson, Nicholas; Moser, Janice M; Guy, Bruno

Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment

基于黄热病疫苗骨架的活病毒疫苗:风险/效益评估的标准化模板及关键考虑因素

Monath, Thomas P; Seligman, Stephen J; Robertson, James S; Guy, Bruno; Hayes, Edward B; Condit, Richard C; Excler, Jean Louis; Mac, Lisa Marie; Carbery, Baevin; Chen, Robert T

Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico

在墨西哥对未感染过黄病毒的成年人进行二价和四价登革热疫苗制剂的评估

Dayan, Gustavo H; Galán-Herrera, Juan-Francisco; Forrat, Remi; Zambrano, Betzana; Bouckenooghe, Alain; Harenberg, Anke; Guy, Bruno; Lang, Jean

Cross-serotype immunity induced by immunization with a conserved rhinovirus capsid protein.

用保守的鼻病毒衣壳蛋白进行免疫接种可诱导交叉血清型免疫

Glanville Nicholas, McLean Gary R, Guy Bruno, Lecouturier Valerie, Berry Catherine, Girerd Yves, Gregoire Christophe, Walton Ross P, Pearson Rebecca M, Kebadze Tatiana, Burdin Nicolas, Bartlett Nathan W, Almond Jeffrey W, Johnston Sebastian L

Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore.

新加坡成人和青少年接种四价登革热疫苗一年后 Th1/Tc1 反应的持续性

Harenberg Anke, Begue Sarah, Mamessier Audrey, Gimenez-Fourage Sophie, Ching Seah Ching, Wei Liang Ai, Li Ng Jun, Yun Toh Xue, Archuleta Sophia, Wilder-Smith Annelies, Shek Lynette P, Wartel-Tram Anh, Bouckenooghe Alain, Lang Jean, Crevat Denis, Caillet Catherine, Guy Bruno